微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Moraxella catarrhalis (Frosch and Kolle) Bovre |
|---|---|
| 商品货号： | TS182030 |
| Strain Designations： | 57135 |
| Isolation： | Sputum, Winnipeg Canada |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | no |
| Antibiotic Resistance： | Macrolide susceptible Susceptible to azithromycin, cefotaxime, cefuroxime, ciprofloxacin, and levofloxacin |
| Comments： | This strain is part of the national surveillance study called CROSS (Canadian Respiratory Organism Susceptibility Study). |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 814: GC Agar/Broth Medium |
| Growth Conditions： | Temperature: 37°C
Atmosphere: 5% CO2 |
| Name of Depositor： | DJ Hoban |
| Special Collection： | ATCC |
| References： | Zhanel GG, et al. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob. Agents Chemother. 47(6):1875-1881, 2003. PubMed: 12760861 |